Available to sourceHuman Prescription DrugNeurological & Psychiatric

Pristiq (desvenlafaxine succinate)

25 mg/1 · Extended-Release Tablet

By Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

NDC: 0008-1210
Route: Oral
Therapeutic class: Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor
Marketing category: NDA

Package sizes

30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1210-30)NDC 0008-1210-30Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Neurological & Psychiatric

See all →

Pristiq (desvenlafaxine succinate)

Package sizes

Additional information

Request this medication

Related in Neurological & Psychiatric

GUNA-MOOD

Neuro Links

Allergy Rescue

New Stock Fungi Mix